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Developments in computational chemistry, bioinformatics, and laboratory evolution have
facilitated the de novo design and catalytic optimization of enzymes. Besides creating useful
catalysts, the generation and iterative improvement of designed enzymes can provide valu-
able insight into the interplay between the many phenomena that have been suggested to
contribute to catalysis. In this work, we follow changes in conformational sampling, elec-
trostatic preorganization, and quantum tunneling along the evolutionary trajectory of a
designed Kemp eliminase. We observe that in the Kemp Eliminase KE07, instability of the
designed active site leads to the emergence of two additional active site configurations.
Evolutionary conformational selection then gradually stabilizes the most efficient configura-
tion, leading to an improved enzyme. This work exemplifies the link between conformational
plasticity and evolvability and demonstrates that residues remote from the active sites of
enzymes play crucial roles in controlling and shaping the active site for efficient catalysis.
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Efficient de novo computational enzyme design has been along-held goal of protein engineers and would allow thecatalytic power of enzymes to be directed towards a range of
industrially and medically important chemical reactions. Studies
have demonstrated that although de novo design is possible, the
imperfect designs often require optimization through laboratory
evolution1,2. Our ability to design enzymes rests upon our fun-
damental understanding of enzyme catalysis, yet the biophysical
and chemical basis for their catalytic efficiency remains a topic of
debate3–5. There is evidence for contributions to catalysis from
electrostatic transition state (TS) stabilization, conformational
changes, and quantum tunneling6–8. Conformational sampling
has been shown to allow enzymes to adopt specific configurations
that are suited to different steps in their catalytic cycle and recent
work has shown how remote mutations can alter the conforma-
tional landscape to increase sampling of certain conformational
substates7,9. Vibrational motions have also been suggested to
contribute to the chemical step in catalysis by altering the
probability of transmission through the TS barrier in some
enzymes by quantum mechanical hydrogen tunneling8,10.
Kemp elimination (proton elimination from 5-nitrobenzisox-
azole; Fig. 1) has been extensively used as a model system in
enzyme design owing to the simplicity of the base-catalyzed ring
opening reaction11 and the absence of natural Kemp eliminases1,
although some enzymes have been shown to catalyze Kemp
elimination promiscuously12,13. Computational design of KE07
involved construction of a theozyme to catalyze the chemical
reaction, which was then grafted into the scaffold of imidazole
glycerol phosphate synthase (HisF) from Thermotoga maritima1.
Catalytically essential residues from the initial design include a
base (Glu101) that facilitates C−H bond cleavage, an H-bond
donor (Lys222) to stabilize the phenoxide intermediate, and a π-
stacking residue (Trp50), which was designed to stabilize the
transition state and favor substrate binding through interactions
with the aromatic ring of the substrate. This initial KE07 design
(Round 1; R1) catalyzes the cleavage of 5-nitrobenzisoxazole (1),
with 103-fold rate acceleration over the noncatalyzed reaction and
a turnover rate (kcat) of 0.018 s−1. Seven generations of directed
evolution then enhanced this turnover-rate over 100-fold1.
Although the improvements to KE07 have been partially
rationalized through experimental and computational character-
ization of the mutant proteins14–17, accounting for the effects of
remote mutations in later rounds has been challenging. KE07 is
not the most efficient of the several Kemp eliminases now
designed18–20, but in the context of understanding how enzyme
activity can be gradually improved through stepwise mutations,
its low efficiency makes it an ideal model system to study the
mechanisms by which evolution or engineering can improve an
inefficient starting point.
In this study we use a combination of protein crystallography,
enzyme kinetics, and computational approaches to investigate the
structure, function, and dynamics of a series of improved variants
of the KE07 series. By soaking crystals of various KE07 variants
with substrate, we capture the enzymes with a series of different
active site configurations. Using molecular dynamics simulations
to investigate the sampling of the different conformational sub-
states, we show that the evolutionary improvement of KE07
involves conformational selection of an alternative, nondesigned,
active site configuration.
Results
Computational design and initial catalytic improvement in
rounds 1–4. To investigate the progressive increase in catalytic
activity, we determined Arrhenius parameters for several variants,
including the activation energy (Ea; associated with the enthalpy
of the reaction) and pre-exponential factor (A; associated with
frequency of collisions between molecules, or entropy) (Table 1).
From R1 to R4 we observe a significant reduction in the Ea, from
10.8 kcal mol−1 (R1) to 5.6 kcal mol−1 (R4), indicating that the
Ile7Asp, Lys146Glu, Gly202Arg, and Asn224Asp mutations
substantially improve the enzyme’s ability to catalyze the reaction,
primarily through enthalpic effects such as an increase in basicity
of the catalytic group or improved TS stabilization. However, the
significant reduction in the activation energy from R1 to R4 was
offset by a less favorable pre-exponential factor (containing the
entropic component, or collision frequency)21 (Table 1).
Analysis of crystal structures of KE07 (Supplementary Data 1),
with and without bound ligands, reveals how the mutations have
increased the basicity of Glu101 and enhanced TS stabilization by
changing the electrostatic character of the active site. The
structure of KE07 R1 was soaked with substrate, allowing us to
obtain a complex with the product of the Kemp elimination
(through in crystallo substrate turnover). At higher pH values
(8.50 vs. 7.25) we observed mixed occupancy between the product
and the histidine tag of a neighboring protein molecule in the
crystal lattice within the active site, presumably because
deprotonation of the structurally analogous imidazole groups
within the histidine tag at basic pH increases its affinity for the
active site (Supplementary Fig. 1). At pH 7.25 we observe almost
full occupancy of the product (Fig. 2a). Compared with the apo-
enzyme, presence of the ligand induces Lys222 to move from the
salt bridge it forms with Glu101 to coordinate the oxyanion of the
product (2). It has previously been shown that once the trajectory
had reached R4, a salt bridge between Lys222 and the Ile7Asp
mutation replaces the Glu101 to Lys222 salt bridge14 (Supple-
mentary Fig. 2), thereby increasing the basicity of Glu101. Indeed,
PROPKA22 suggests the pKa of Glu101 increases from 4.49 (R1)
to 6.04 (average of six chains in R4; 3IIO (3IIO)).
N
O
NO2 NO2 NO2
N
O
H
O
H
O
H
HO
N
B-OH
1 2 3
Base
A
B
A
H
Acid
1
3
5
6
7
2
4
Fig. 1 Reaction scheme for the Kemp elimination of 5-nitrobenzisoxazole. The nucleophilic oxygen atom of the base (B) donates electrons to the
electrophilic 3′-H of 5-nitrobenzisoxazole and the electronegative oxygen atom of the isoxazole group forms a hydrogen bond with an acid (A) (1), forming
a transition state in which the C−H and N−O bonds are weakened (2). The removal of the 3′-H from the substrate leads to an anionic phenoxide
intermediate, which is then protonated, forming the final product (3)
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To test whether these in crystallo and in silico observations
were consistent with the enzyme in vitro, we used fluorescence
spectroscopy. Trp50 in the active site of KE07 is a convenient
spectroscopic handle to interrogate the active site environment (a
second tryptophan residue, Trp156, is invariant throughout
evolution; Supplementary Fig. 3). A Trp50Ala mutation was
made in KE07 R1 to assess the contribution of Trp50 to the
fluorescence; the crystal structures showed no major changes to
the active site nor overall fold (Supplementary Fig. 4). This
showed that the overall fluorescence of the R1 Trp50Ala mutant
was slightly lower than R1, which is consistent with some
quenching of the fluorescence of Trp156 by Trp50, similar to
what has been reported previously23. It also revealed that the
temperature dependence of KE07 R1 fluorescence is due to
Trp50, with the fluorescence of the Trp50Ala variant showing
almost no temperature dependence (Supplementary Fig. 3C). We
observe that the Trp fluorescence of KE07 increases substantially
from R1 to R4, which can reasonably be attributed to the
changing environment of Trp50, given all of these mutations are
in close vicinity (Fig. 3, Supplementary Fig. 2, Supplementary
Table 1). The increase in fluorescence is consistent with increased
negative charge on Glu101, as it has been shown that negative
charge (i.e. on Glu101, which is sandwiched between Trp50 and
Tyr128; Supplementary Fig. 2) will increase the quantum yield
from tryptophan if it is closer to an acceptor (Tyr128) than
the indole ring (Trp50)24. The temperature dependence of
the fluorescence also increases from R1 to R4, consistent with
the environment around Trp50 becoming more polarized
(Supplementary Fig. 2). Thus, the solution spectroscopic behavior
of KE07 R1 and R4 is consistent with the structural observations.
The loss of the salt-bridge to Lys222 reduces any H-bonding
conformational constraint on the catalytic general base Glu101,
which suggests that increased disorder of the catalytic residue is a
plausible cause of the less favorable pre-exponential factor in R4.
We examined the conformational sampling of Glu101 in R1 and
R4 via Hamiltonian replica exchange molecular dynamics
(HREX-MD) simulations (Fig. 3). The simulations show that
the disorder of Glu101 does indeed increase from R1 to R4
(Fig. 3b). Therefore, although the electrostatic environment of
KE07 may have changed to lower the activation energy, the
probability of the enzyme substrate complex colliding in the
correct orientation is also reduced, owing to the increased
disorder of the catalytic group (Glu101), resulting in a catalytic
trade-off between Ea and A (Table 1).
Catalytic improvement through conformational selection. In
contrast to the improvement in turnover rate across the first four
rounds of mutagenesis, which was unambiguously the result of
reduced activation energy due to changes to the local electro-
statics of the active site via mutations within and near the active
site, the catalytic efficiency of R5 and R6 is improved by more
favorable collision frequency (the activation energy actually
increases) (Table 1). Thus, the mechanism by which the remote
mutations that appear in R5 and R6 increase activity is qualita-
tively different. This is mirrored in their location within the
protein; in contrast to the initial mutations that affect the active
site directly, the mutations in R5 (Val12Met) and R6 (Lys146Thr)
are remote from the active site (Supplementary Table 2). The
mutations in R7 and R7-2 (Phe77Ile, Phe229Ser, Ile102Phe) result
in further optimization of activation energy.
To understand the effect of these remote mutations on
catalysis, crystals of KE07 R5 and R6 were soaked with substrate
before flash-cooling to 100 K and data collection (Supplementary
Data 1). Soaking of the genuine substrate was preferred to
cocrystallization with an analog, to eliminate any possible
artifacts that changes to the chemistry of the substrate could
produce. We tested a variety of cryobuffers and crystallization
conditions. When glycerol was used as the soaking buffer in R5,
we captured the active site in the designed conformation, into
which we were able to soak substrate to capture the product
bound state (Fig. 2b). In contrast, when MPD was used as the
cryobuffer, we captured the active site in a different configuration,
with the tryptophan residue in the active site rotating ~100°
(Fig. 2c). This configuration has been observed previously in R7,
although it was thought to be an artifact due to the presence of
the histidine tag from a neighboring protein molecule14. We were
able to capture the slow substrate monodeuterated (at the 3′-
hydrogen) 5-nitrobenzisoxazole bound to this configuration
(hereafter denoted configuration B) in a catalytically competent
orientation, with C3 pointed towards the general base Glu101
(which undergoes rearrangement upon ligand binding to orient
towards the substrate). These results demonstrate that substantial
conformational change occurs from R5, with both configurations
capable of binding substrate in a catalytically competent fashion.
We also solved a higher resolution structure (1.61 Å) of R6, in
which the active site of both monomers in the asymmetric unit
were observed to be fully in configuration B, with the imidazole
ring (an analog of the benzisoxale substrate) of the histidine tag of
a neighboring KE07 molecule in the crystal lattice bound to the
active site (Supplementary Fig. 1). For R7 and R7-2, we were able
to capture the active site in configuration A when glycerol/Bis-
Tris was used as cryoprotectant (Fig. 2e), and configuration B
with the neighboring hexahistidine tag bound and MPD used as
cryoprotectant (Fig. 2g). However, the most striking result came
from a crystal structure with 12 different KE07 molecules within
the asymmetric unit‚ into which substrate was soaked. In this
structure, we observe both configuration A (three subunits) and B
(one subunit) (Supplementary Fig. 5), as well as two additional
configurations (hereafter denoted configurations C and D). In
configuration C, Trp50 is rotated back to a similar position as the
designed conformation, except it is rotated such that the NH of
the indole ring can hydrogen bond to the catalytic Glu101. The
four subunits in configuration C all had product bound (Fig. 2f;
Table 1 Arrhenius parameters
KE07 variant akH (s−1) aKM (H) (mM) akcat/KM (H) (s−1∙M−1) Ea(H)b Ea(D) Ea(D)−Ea(H) lnAH lnAD AH/AD kH/kD
cB 3.25E-05 (1E-06) — — 14.5 (0.8) 16.7 (0.7) 2.3 (1.1) 13.7 (1.4) 16.0 (1.1) 0.107 (0.01) 4.6 (0.1)
R1 0.02 (0.0008) 0.96 (0.06) 24.5 (1.8) 10.8 (1.1) 15.1 (1.0) 4.3 (1.5) 14.0 (1.8) 19.6 (1.7) 0.004 (0.0006) 4.9 (0.2)
R4 0.96 (0.09) 1.10 (0.17) 877 (159) 5.6 (0.8) 9.8 (0.8) 4.2 (1.2) 9.1 (1.3) 14.4 (1.4) 0.005 (0.0009) 5.6 (0.2)
R5 1.43 (0.06) 0.53 (0.05) 2700 (257) 7.7 (0.8) 9.0 (0.7) 1.4 (1.1) 12.9 (1.3) 13.0 (1.2) 0.875 (0.1211) 8.6 (0.2)
R6 1.56 (0.07) 0.50 (0.05) 3100 (332) 9.5 (0.5) 11.7 (0.5) 2.2 (0.7) 16.1 (0.8) 17.8 (0.8) 0.181 (0.0126) 6.5 (0.1)
R7 2.51 (0.14) 0.58 (0.07) 4310 (568) 7.1 (0.7) 11.0 (0.9) 4.0 (1.1) 12.5 (1.1) 17.1 (1.5) 0.009 (0.0011) 7.0 (0.2)
R7-2 3.83 (0.17) 0.55 (0.05) 6970 (669) 6.9 (0.4) 11.3 (0.5) 4.4 (0.6) 12.7 (0.7) 18.1 (0.8) 0.005 (0.0003) 7.3 (0.1)
aValues, at 303 K, were from Michaelis–Menten saturation curves for the enzyme reaction using a substrate concentration range of 0.1–1.2 mM of 5-nitrobenzisoxazole from two independent
experiments
bEa is in kcal mol−1. Ea, ln A and kH/kD values were calculated from the Arrhenius equation from rate constants measured at a range of temperatures (283–323 K) at pH 7.25 from three independent
experiments. Arrhenius equations are shown in the Methods section and Arrhenius plot is shown in Supplementary Fig. 11. Propagated standard errors in the fitted parameters are in parentheses
cB stands for the nonenzymatic reaction rate in buffer
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Supplementary Fig. 5), and were the only chains where product
was observed. Four subunits were observed to adopt configura-
tion D, in which Trp50 was disordered in-between the
well-defined configurations, supporting the idea that these
conformational substates exist in equilibrium (Supplementary
Fig. 5). Finally, crystals of R7-2 with the hexahistidine tag
crystallized in configuration B with the hexahistidine tag in the
active site (even when soaked with substrate) (Fig. 2g). However,
when we removed the hexahistidine tag, we captured a high-
resolution structure in configuration C with product bound
(configuration A was present in low occupancy; Fig. 2h).
Altogether, we have characterized the emergence of two
additional catalytically competent active site configurations in
KE07 that were not part of the original design, have used
substrate soaking and flash cooling to demonstrate that all three
can bind substrate in catalytically competent orientations, and
show that within the population of enzyme molecules within a
single crystal, all three (and an intermediate state) can be
sampled. However, in later generations (R7 and R7-2) evidence
for turnover was only observed with configuration C.
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Fig. 3 Molecular dynamics and tryptophan fluorescence of KE07 variants.
Conformational sampling of a Trp50 and b Glu101 during KE07 evolution in
Hamiltonian replica exchange molecular dynamics (HREX-MD) simulations
and c tryptophan fluorescence spectra over a temperature range 283−323
K. The dihedral angle distributions of Trp50 (a) and Glu101 (b) of the KE07
variants (R1 to R7-2) are shown. Initial Trp50 conformations, together with
the backbone RMSD profiles, are shown in Supplementary Fig. 7. The atoms
used for dihedral angle analysis are χ1: N:CA:CB:CG, χ2: CA:CB:CG:CD1 of
Trp50 (a). χ2: CA:CB:CG:CD, χ3: CB:CG:CD:OE1 of Glu101. The protein
structures indicate the labeling used for the different Trp50 and Glu101
conformers sampled by KE07 variants. c Fluorescence emission spectra
(excitation at 280 nm) were measured at 283−323 K (temperatures for
each spectra are indicated with different colors). The fluorescence spectra
of Trp50Ala mutants (R1_Trp50Ala and R7-2_Trp50Ala) are shown in
Supplementary Fig. 3
a b
Glu101
Trp50(A)
c d
Trp50(B)
e f
Trp50(C)
g h
Fig. 2 Crystal structures of different KE07 variants with and without ligand.
a R1 in configuration A with bound product after substrate soaking. b R5 in
configuration A with bound product after substrate soaking. c R5 in
configuration B with bound MPD after cryoprotection. d R5 in configuration
B with both MPD and substrate bound after substrate soaking. e R7 in
configuration A with bound Bis-Tris molecule after cryoprotection. f R7 in
configuration C with bound product after substrate soaking. g R7-2 in
configuration B with bound hexahistidine tag from an adjacent protein chain
after cryoprotection. h R7-2 in configuration C with bound product after
substrate soaking, minor occupancy of configuration A is also observed.
Ligands and alternative conformations of residues are shown as pink sticks.
The mFo-DFc omit maps are shown as green meshes and contoured at 3.0σ.
The 2mFo-DFc maps are shown as blue meshes and contoured at 1.0σ. PDB
ID of the structures: a (5D2W), b (6DKV), c (6C7M), d (6DNJ), e (6CAI),
f (6DC1), g (5D38), h (6CT3)
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The structural basis for the dramatic reorganization of the
active site of KE07 is coincident with the introduction of remote
mutations and appears to involve differential stabilization of the
three conformational substates. For example, Ile102Phe results in
phenylalanine filling a hydrophobic cavity and a small adjustment
of the main chain, which increases the distance between Glu101
and Trp50, allowing sampling of the Trp50 rotamer, which is
then stabilized by an H-bond to Glu101, thereby stabilizing this
alternative configuration (Supplementary Fig. 6). The Val12Met
and Phe77Ile mutations, also in the second shell, cause changes to
internal cavities that cause a slight rotation in the backbone at
Trp50 that also favors the alternative configuration (Supplemen-
tary Fig. 6). From configuration B, the enzyme can more easily
access configuration C as the indole ring has already rotated at
this point.
The crystallography provides valuable snap-shots of different
configurations that the active site can adopt, and using different
buffers, we were able to selectively stabilize certain configurations,
but the crystallography does not tell us much regarding their
relative populations in solution (other than that they can all be
sampled). To the solution sampling of these states, we used
HREX-MD simulations, which are among the most comprehen-
sive computational methods to investigate conformational
sampling25. These results were consistent with the crystallography
and kinetic analysis: whereas in R1 (original design), configura-
tion A was the dominant substate that was sampled, by R5 we
observe increased sampling of configurations B and C (Fig. 3;
Supplementary Fig. 7). By R7 and R7-2, configuration C (which
was the only state we saw associated with product in the crystal
structures) becomes the dominant substate sampled, with
configurations A and B sampled only rarely. These simulations
also reveal that the mobility of Glu101 was reduced as a result of
the hydrogen bond formed to the indole nitrogen of Trp50 in R5;
this could account for the improved pre-exponential factor from
R5 onwards (Figs. 2,3).
We again used tryptophan fluorescence to complement the
crystallographic and computational analyses. In contrast to the
increase in Trp50 fluorescence intensity over the first half of the
evolutionary trajectory owing to the increased negative charge
of Glu101, the fluorescence intensity decreases to below the
level of R1 from R4 to R7-2 (Fig. 3; Supplementary Table 1).
This marked reduction in fluorescence intensity is coincident
with the introduction of remote mutations (generally con-
servative in terms of charge) that are unlikely to directly affect
the local electrostatic environment of Trp50. The loss of
fluorescence is consistent with the alternative active site
configurations (B and C), in which Trp50 fluorescence is
quenched: either via H-bonds with Glu101 in configuration B
(it has been shown that H-bonding between the –NH atom of
tryptophan and negatively charged amino acids leads to
fluorescence quenching26) or by solvent in the case of
configuration C. It is notable that the reduction in fluorescence
intensity is gradual, consistent with the progressive enrichment
of the active site configuration C we observe in the MD
simulations of structures between R5 and R7-2. A Trp50Ala
mutant of R7-2 was made to compare against R1_Trp50Ala; no
change in fluorescence intensity was observed other than ~15%
lower intensity at 293 K in R7-2_Trp50Ala compared to
R1_Trp50Ala due to the absence of two solvent accessible
phenylalanine residues (Phe77Ile, Phe229Ser) (Supplementary
Fig. 3, Supplementary Table 1). The Trp50Ala mutants in R1
and R7-2 result in significant (>95%) reductions in kcat,
although the KM of R7-2_Trp50Ala increased sevenfold,
whereas the KM of R1_Trp50Ala was unchanged, suggesting
more involvement of Trp50 in substrate binding in the evolved
configuration C (Supplementary Table 3).
One enzyme: three active site configurations. The structural,
spectroscopic and computational results suggest that KE07 has
evolved through maximizing the sampling of an active site con-
figuration (C). To investigate whether the active site configura-
tions that become enriched by R7-2 are catalytically competent,
we performed empirical valence bond (EVB) simulations27 of the
Kemp elimination, as catalyzed by variants R1 (configuration A),
R5 (configurations A and B), R7 (configurations A and B) and
R7-2 (configurations B and C). The EVB method describes che-
mical reactivity within a valence bond framework using classical
force fields, and has been successfully applied to the investigation
of the Kemp elimination reaction in enzymes15,28. The reaction
was modeled based on the valence bond states shown in Sup-
plementary Fig. 8 and the resulting calculated activation-free
energies, which are in excellent agreement with experiment, are
shown in Supplementary Table 4. It is notable that configurations
B and C are consistently better than the original, designed con-
figuration (A).
Figure 4 shows the substrate positioning relative to key active
site residues in the Michaelis complexes and transition states
for the reactions catalyzed by the R7 or R7-2 A, B,
and C configurations (Supplementary Fig. 9, Supplementary
Tables 5-7). Firstly, and most importantly, these calculations
confirm that both configurations B and C are similarly
catalytically competent, i.e. the configurations are bona fide
catalytic states. We observe, as in previous studies14–17, that
removal of the Glu101-Lys222 salt bridge appears to increase the
pKa/charge of the Glu101 side chain by ~2 pKa units
(Supplementary Table 5), while the electrostatically unfavorable
contribution of Lys222 to the calculated activation-free energy is
substantially reduced by the removal of this salt bridge
(Supplementary Fig. 10). In the most evolved versions of the
three configurations we obtained from our structural studies (R7,
A; R7-2, B; R7-2, C), configurations B and C displayed lower
energy barriers than A (16.8 and 16.4 vs. 19.0 kcal mol−1,
respectively; Supplementary Table 4), which is consistent with
the gradual conformational selection of state C along the
trajectory. The reason for the increased efficiency of state C
seems to be an accumulation of many small effects (we will focus
on the A:C comparison since C was the state that was primarily
selected). First, for all three Trp50 configurations, the substrate
position is stabilized through π-stacking interactions with the
Trp50 side chain. However, the Trp50:substrate alignment is on
average slightly better in conformation C than conformation A
(11.3 vs. 14.6°) (Fig. 4; Supplementary Table 7) consistent with
the kinetic analysis showing that the Trp50Ala mutant had a
greater effect on KM in R7 than in R1 (Supplementary Table 3).
Second, the orientation of the reactants in state C is also better
than state A (donor-H-acceptor angle of 160.4° vs. 149.5°).
Finally, the pKa of the catalytic Glu101 is predicted to be higher in
configuration C than configuration A (7.5 vs. 6.1) owing to
differences in the microenvironment of the active site due to the
Trp50 rotation, which is again consistent with the experimentally
determined changes in pKa14. Altogether, these results support
the experimental observations: specifically, catalytically compe-
tent active site configurations emerged from disorder and the
arrangement of the amino acids in these states (particularly
configuration C) was superior to the original design, resulting in
evolutionary conformational selection.
The role of quantum tunneling. Primary kinetic isotope effects
(1° KIEs) occur when atoms that are directly involved in the
reaction are replaced with heavier isotopes (e.g. hydrogen for
deuterium) and can reveal much about the nature of the catalytic
mechanism. Using hydrogenated and monodeuterated (at the 3′-
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hydrogen) 5-nitrobenzisoxazole29,30, we determined the activa-
tion energy (Ea) and pre-exponential factor (A) for the reaction in
aqueous solution (Table 1). Given that hydrogen abstraction is
the rate-limiting step in the Kemp elimination reaction11, it was
not surprising that ring opening in the deuterated analog
occurred more slowly (Table 1, Supplementary Fig. 11). The
relative rates of the hydrogenated and deuterated analogs allow
calculation of the 1° KIEs for this reaction, yielding a value of 4.9
at 298 K. To investigate the contribution of quantum tunneling to
this 1° KIE, the H abstraction by a hydroxide ion-water cluster (–
OH•(H2O)4) was studied from first principles (Supplementary
Fig. 12), using quantum chemistry31. The free energy activation
barrier for H abstraction by the hydroxide ion-water cluster in the
water continuum solvent model is consistent with previous work
(17.4 vs. 19.8 kcal mol−1)31. Gas-phase calculations reveal that the
H abstraction process is diffusion controlled without explicit H2O
molecules to stabilize the reactive –OH (Supplementary Table 8,
Supplementary Fig. 13). QM/MM calculations were carried out
with Polyrate in the H abstraction step of the intermediate
complex (with the rate constant kcat), and the corresponding
values of the tunneling coefficients κ for the hydrogenated and
deuterated molecules between 283 and 323 K are given in Sup-
plementary Table 9. As expected, tunneling is greater for the
lighter hydrogen isotope, with a tunneling-corrected KIE of 5.8
for the reaction from the pre-complex at 298 K, and 5.8 at 298 K
when starting from the isolated reactants. These results establish
that although quantum tunneling is likely to occur in solution
and contribute to the magnitude of the KIE, its overall con-
tribution to the reaction rate is likely to be relatively small.
Given that the theoretical calculations show some level of
quantum tunneling in solution, and recent work has implicated
quantum tunneling in enzyme catalysis and molecular
evolution8,10, we investigated the magnitude of the KIE across
the trajectory; if enhanced quantum tunneling were selected for
throughout evolution, as has been proposed5, a substantial
increase in the magnitude of the KIEs would be expected. Our
results reveal that although there were transient changes to the
KIEs in the middle of the evolutionary trajectory (Ea(D) vs. Ea(H)
and AH/AD values at R5 and R6), the KIEs from the start (R1) and
end-point (R7-2) were very similar (Table 1, Fig. 5). Notably, R1
and R7/R7-2 are both relatively conformationally stable, as judged
by the molecular dynamics simulations and tryptophan fluores-
cence spectroscopy. The anomalous KIEs observed in R5−R6
correlate with the increased sampling of the alternative active site
configurations (Fig. 5). This is notable because QM/MM
calculations have previously shown that, when the conforma-
tional coordinate is included in the catalytic model, the presence
of distinct active site configurations with different catalytic
efficiencies (as observed here) can account for anomalous KIEs
without the need to invoke large changes in quantum effects.4 It
therefore appears that evolution has not involved optimization of
short-timescale (fs) vibrations that could enhance quantum
tunneling in this example.
Discussion
In this work, we have followed the iterative improvement of a
designed enzyme, dissecting the respective contributions of
a b c
d e f
Fig. 4 Snapshots of three different binding modes from computer simulations. A comparison of representative structures of the equilibrated a−cMichaelis
complexes and d−f transition state structures for the Kemp elimination of 5-nitrobenzisoxazole catalyzed by (a, d, green sticks) R7 with Trp50 in
conformation A (b, e, pink sticks) R7-2 with Trp50 in conformation B, and (c, f, cyan sticks) R7-2 with Trp50 in conformation C. This figure highlights the
shift in substrate position and key interacting residues upon rotation of the Trp50 side chain. The snapshots shown here correspond to the top ranked
cluster obtained by RMSD clustering of the EVB simulations, as described in the Methods
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Fig. 5 Preorganization and primary kinetic isotope effects in KE07 evolution.
Activation energy KIEs (a) and pre-exponential factor KIEs (b). Error bars
denote propagated standard errors in the fitted parameters to Arrhenius
plot (Supplementary Fig. 11) from three independent experiments
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various effects on catalysis. In addition to traditionally considered
effects, such as mutations increasing the basicity of a catalytic
residue (e.g., Glu101), our results highlight the significance of
catalytic tradeoffs: the same mutational changes that alter active
site electrostatics can lead to disorder that is detrimental to cat-
alysis32. Other effects, such as quantum tunneling, are not
observed to significantly change in this evolutionary process, nor
to greatly differ from the level of tunneling that normally occurs
in solution.
The most unusual observation in this work was that a series of
remote point mutations could completely remodel the designed
active site, via subtle changes that involve filling internal cavities
and backbone adjustments, leading to a single enzyme that is able
to sample three different active configurations, each with different
catalytic efficiency. Conformational selection of the most efficient
configuration then produced a superior enzyme. Conformational
selection has been observed in the optimization of catalytic pre-
cision in other designed enzymes2,19,33, but the scale of the
conformational reorganization observed here is particularly
notable. Alongside our KIE data, our results suggest that to
accurately model enzyme catalysis by populations of con-
formationally heterogeneous enzymes, catalytic models should
incorporate multiple conformational substates comprising dif-
ferent active site geometries with different catalytic efficiencies4.
These results highlight the remarkable conformational plasti-
city of proteins and the degree to which the configuration of an
active site can be modulated by the amino acid composition of the
second shell. It is notable that the selection of nondesigned active
site conformations through directed evolution appears to be more
common when working with computationally designed
enzymes19. We suggest that this could be due to less focus on the
optimization of outer-shell residues to stabilize the active site
geometry, in comparison to naturally evolved enzymes in which
the composition of the outer-shell has evolved over many gen-
erations to stabilize active sites via multiple mechanisms9. This
study adds to an emerging view in which the conformational
plasticity of proteins underpins their remarkable evolutionary
potential34 and establishes that, provided the active site contains
the necessary catalytic machinery, it is the outer-shell amino acids
that provide most of the catalytic power of enzymes by posi-
tioning the active site correctly for catalysis and allowing it to
sample alternative conformations for substrate and product
diffusion.
Methods
Mutagenesis and protein purification. KE07 variants, cloned into the pET-29b
(+) vector (Invitrogen), were expressed with C-terminal His6-tags in Escherichia
coli BL21(DE3) cells (Invitrogen). The cell pellet was resuspended in buffer A (50
mM Tris-HCl pH 8.0, 100 mM NaCl, 20 mM imidazole) and lysed with a French
pressure cell press (Thermo Fisher). The soluble fraction was loaded onto a Ni-
NTA column (Qiagen) and elution was achieved with buffer B (50 mM Tris-HCl
pH 8.0, 100 mM NaCl, 250 mM imidazole). After extensive dialysis against elution
buffer (25 mM HEPES-NaOH pH 7.25, 100 mM NaCl), protein concentrations
were determined using a NanoDrop spectrophotometer (Thermo Fisher) at 280 nm
and SDS-PAGE gel electrophoresis. Extinction coefficients for each of the KE07
variants at 280 nm were calculated using ProtParam35. The proteins were con-
centrated (10–30 mgml−1) and stored at 4 °C. Gibson assembly-based mutagen-
esis36 was used to introduce the Trp50Ala substitution into the KE07 R1 and KE07
R7-2 plasmids.
Kemp elimination kinetics. Kemp elimination of 5-nitrobenzisoxazole (PubChem
CID: 142385) results in the formation of 2-cyano-4-nitrophenol (PubChem CID:
11116377). The product has maximum absorbance at 380 nm (molar absorption
coefficient of 15,800 M−1 cm−1 in water)11. The rate of product formation was
monitored via absorbance at 380 nm using a Cary 60 UV−Vis spectrophotometer
(Agilent Technologies) or a SpectraMax-M2 Multi-mode microplate reader
(Molecular Devices). Full Michaelis−Menten kinetics were collected at each point.
Reaction rates were measured in buffer containing 25 mM HEPES-NaOH pH 7.25,
100 mM NaCl at a range of temperatures (10, 20, 25, 30, 35, 40, 45, 50 °C). To
increase substrate solubility 1.25% (v/v) glycerol was included in the assay buffer.
Substrate stocks in acetonitrile (final concentration of acetonitrile 1–1.5% v/v) at
9−11 different concentrations (0.01−1.1 mM) were added to the enzyme-buffer
mixture immediately before the measurement due to the water sensitivity of the
substrates. The rate of the background reaction was subtracted before fitting the
data for enzyme-catalyzed reactions to a kinetic model. The activation energies (Ea)
and the pre-exponential factors (A) were obtained from Arrhenius plots. The plot
of ln(k) against 1/T gives a straight line with slope –Ea/R and y-intercept ln(A),
according to the linear form of the Arrhenius equation (Eq. 1).
ln kð Þ ¼ ln Að Þ  Ea
R
1
T
 
; ð1Þ
where A, R, k, and T are pre-exponential factor, gas constant, reaction rate, and
temperature in Kelvin, respectively. The activation energy Ea was calculated from
the slope of the Arrhenius plot. A is calculated from the y-intercept of the plot.
Substrate synthesis. 5-nitrobenzisoxazole was prepared from 1,2-benzisoxazole
(Sigma, >99%) following the published protocol37: 2 ml (2.3 g) of 1,2-benzisoxazole
was dissolved in concentrated H2SO4 (20 ml) in a flask (placed on the salt−ice
mixture), then 2 ml mixture of H2SO4 (1 ml) and HNO3 (3 ml) was slowly added to
the 1,2-benzisoxazole mixture. The solution was stirred for 30 min. Fifty milliliters
of ice−water mixture was added to the stirred mixture and the filtered crude
product was recrystallized by solvating it to heated anhydrous ethanol (70–80 °C)
then slowly cooled and filtered. The yield of 2 days vacuum-dried product was
3.3 g. 3-Deutero-5-nitrobenzisoxazole was synthesized from 2-bromophenol fol-
lowing the published procedures29,30. The substrate synthesis scheme is shown in
Supplementary Fig. 14 and consists of four steps:
(1) - 2-(2-Bromophenoxy)tetrahydro-2H-pyran: Pyridinium p-toluene
sulfonate (754 mg, 3.00 mmol) was added to a solution of 2-bromophenol (3.48 ml,
30.00 mmol) and 2,3-dihydropyran (4.11 ml, 45.00 mmol) in dry CH2Cl2 (20 ml).
The resulting mixture was stirred for 21 h under an atmosphere of nitrogen at
room temperature. Thereafter, the reaction mixture was quenched with sat. aq.
NaHCO3 (20 ml) and the resulting phases separated. The aqueous phase was then
back-extracted with CH2Cl2 (3 × 20 ml) and the organic phases were combined,
dried over Na2SO4, filtered and the filtrate concentrated in vacuo. The residue was
adsorbed to silica and purified by flash chromatography (SiO2, EtOAc:Hex (1:10))
to give 1 (6.61 g, 86%) as a colorless oil. 1H NMR (400MHz, CDCl3) δH 7.54 (dd,
J= 7.8, 1.6 Hz, 1 H), 7.24 (ddd, J= 7.4, 7.4, 1.6 Hz, 1 H), 7.16 (dd, J= 8.6, 1.2 Hz, 1
H), 6.87 (ddd, J= 7.8, 7.4, 1.6 Hz, 1 H), 5.53 (t, J= 2.7 Hz, 1 H), 3.92 (ddd, J= 11.0,
3.1 Hz, 1 H), 3.67−3.57 (m, 1 H), 2.19−2.05 (m, 1 H), 2.04−1.95 (m, 1 H), 1.94
−1.83 (m, 1 H), 1.80−1.59 (m, 3 H). 13C NMR (100MHz, CDCl3) δC 153.4, 133.2,
128.3, 122.7, 116.6, 113.1, 96.6, 61.8, 30.2, 25.2, 18.3. MS (EI+) m/z 258 (10%,
[M, 81Br]+), 256 (10%, [M, 79Br]+).
(2) - 2-α-Deuterio-(tetrahydropyran-2-yloxy)benzaldehyde: A solution of 2.2 M
n-BuLi in hexanes (4.62 ml, 10.27 mmol) was added dropwise to a solution of 1
(2.64 g, 10.27 mmol) in dry Et2O (20 ml) at 0 °C under an atmosphere of nitrogen.
The resulting mixture was allowed to stir for 2 h at 0 °C. Thereafter, a solution of
[D7]-DMF (879 μl, 11.29 mmol) in dry Et2O (5 ml) was added and the solution was
stirred, allowing to warm to room temperature for 17 h. Thereafter, the reaction
was quenched by addition of D2O (20 ml) and the resulting layers were separated.
The aqueous phase was back-extracted with Et2O (3 × 15 ml) and the organic layers
were combined, dried over Na2SO4, filtered and the filtrate concentrated in vacuo.
The residue was purified by flash chromatography (SiO2, Et2O:Hex (1:3)) to give 2
(2.01 g, 94%) as a colorless oil. 1H NMR (400 MHz, CDCl3) δH 7.85 (s, 1 H), 7.56
−7.50 (m, 1 H), 7.27−7.23 (m, 1 H), 7.10−7.04 (m, 1 H), 5.59 (t, J= 2.7 Hz, 1 H),
3.94−3.85 (m, 1 H), 3.72−3.62 (m, 1 H), 2.09−1.87 (m, 3 H), 1.83−1.56 (m, 3 H).
13C NMR (100MHz, CDCl3) δC 175.8, 159.5, 135.8, 128.0, 121.5, 115.4, 96.4, 62.1,
30.1, 25.0, 18.5. MS (EI+) m/z 207 (5%, [M]+), 123 (100%, [M-THP]+).
(3) - α-Deuterio-2-hydroxybenzaldehyde: A solution of 1 M DCl in D2O (10 ml)
was added to a solution of 2 (2.01 g, 9.91 mmol) in dry THF (10 ml) under an
atmosphere of nitrogen and the resulting solution was stirred for 17 h. Thereafter,
the reaction mixture was diluted with D2O (10 ml) and the resulting mixture
extracted with Et2O (3 × 20 ml). The organic layers were combined, dried over
Na2SO4, filtered and the filtrate concentrated in vacuo. The residue was purified by
flash chromatography (SiO2, EtOAc:Hex (1:10)) to give 3 (915 mg, 75%) as a
colorless oil. 1H NMR (400MHz, CDCl3) δH 11.05 (s, 1 H), 7.06–7.51 (m, 2 H),
7.06-6.97 (m, 2 H). 13C NMR (100MHz, CDCl3) δC 196.5, 161.7, 137.0, 133.7,
119.8, 117.6. MS (EI+) m/z 123 (100%, [M]+).
(4) - 3-Deuterio-5-nitrobenzo[d]isoxazole: Hydroxylammonium O-sulfonate
(966 mg, 8.54 mmol) was added to a solution of 3 (700.8 mg, 5.69 mmol) in EtOH
(3.5 ml) under an atmosphere of nitrogen and the resulting solution was stirred for
30 min (over which time the mixture clarified). CH2Cl2 (15 ml) was added and the
mixture was cooled to 0 °C and a solution of NaHCO3 (1.05 g, 12.49 mmol) in D2O
(7 ml) was added dropwise with the evolution of gas and the resulting mixture was
stirred for a further 30 min. Thereafter, the resulting layers were separated and the
aqueous layer back-extracted with CH2Cl2 (4 × 10 ml). The organic layers were
combined, dried over Na2SO4, filtered and the filtrate concentrated in vacuo to
give a colorless oil that was used without further purification. A mixture of HNO3
(0.4 ml) and H2SO4 (0.15 ml) was added to a solution of the colorless oil (701 mg,
5.83 mmol) in H2SO4 (3.6 ml) at 0 °C under an atmosphere of nitrogen. The
resulting solution was stirred for 30 min and then was carefully poured into a
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mixture of ice and water (50 ml, 1:1). The resulting precipitate was collected and
recrystallized from dry EtOH to give the final product (273 mg, 28% over two
steps) as a colorless solid. 1H NMR (400MHz, CDCl3) δH 8.73 (d, J= 2.0 Hz, 1 H),
8.52 (dd, J= 9.2, 2.0 Hz, 1 H), 7.77 (d, J= 9.2 Hz, 1 H). 13C NMR (100MHz,
CDCl3) δC MS (EI+).
X-ray crystallography. Crystals of all KE07 variants except one (R7-2 with pro-
duct) were grown at 4 °C by hanging-drop vapor diffusion. Equal volumes of
reservoir solution (12–25% PEG 3350, 0.1 mM Bis-Tris Propane pH 8.5) or (25mM
HEPES-NaOH pH 7.25, 100mM NaCl) were mixed with protein (5–30mgml−1)
and crystals reached maximum size after 7–60 days of incubation. One of the R7-2
crystals was grown by mixing 2 μl of reservoir solution (0.5 M (NH4)2SO4, 0.8M
Li2SO4, 0.1M Na3citrate pH 5.6) and 1 μl of protein (11mgml−1), the crystals
reached maximum size after 1–2 months at 18 °C. 35% polyethylene glycol
(PEG400), 35% 2-methyl-2,4-pentanediol (MPD), 35% glycerol or 35% PEG3350
were used as a cryoprotectant. Crystals were soaked in a solution containing 35%
MPD and 0–7.5mM 5-nitrobenzisoxazole and for between 10 s and 40 min before
vitrification in nitrogen at 100 K. Crystallographic data were collected at 100 K at
the Australian Synchrotron (MX1/MX2, 0.9537 Å) except (5D2V) (Australian
National University (MarμX, 1.5418 Å)). The obtained diffraction data were indexed
and integrated with XDS38. Resolution estimation and data truncation were per-
formed on the basis of the datasets overall half-dataset correlation, a CC1/2 value of
0.3–0.539. All structures were solved by molecular replacement using the Molrep
program in CCP440 using either the structure deposited under PDB accession code
(2RKX) or (3IIV) as a starting model. The models were refined using phenix.
refine41, and the model was subsequently optimized by iterative model building with
the program COOT v0.742. The alternative conformations were modeled based on
mFo-DFc density and the occupancies and B-factors were determined using phenix.
refine41. The structures were then evaluated using MolProbity in Phenix. Details of
the refinement statistics were produced by Phenix v1.943 and summarized in
Supplementary Data 1. Figures were made using PyMol v1.744.
Fluorescence measurements. Tryptophan fluorescence was measured using a
Cary Eclipse Fluorescence Spectrophotometer with a Single Cell Peltier Accessory
for temperature control (Agilent Technology). Tryptophan was excited at 280 nm
(slit width 5 nm) and emission was monitored between 300 and 400 nm (1.5 nm slit
width). Purified KE07 protein was diluted (1.8–5 μM) in buffer (25 mM HEPES pH
7.25, 100 mM NaCl) and the spectra were measured at 283–323 K.
Computer simulations. HREX-MD simulations: HREX-MD simulations were
performed in GROMACS 5.1.445 patched with PLUMED 2.3.046. The simulations
were initiated from the following starting structures: PDB IDs (5D2W) for R1,
(3IIO)14 chain A for R4,(5D30) for R5,(5D32) chain A for R6, (5D33) chain A for
R7, and (5D38) chain A for R7-2. The His-tags were removed, and the protonation
states for titratable residues were set according to PROPKA22 calculations at pH of
7.25, i.e., all Asp and Glu were deprotonated, Lys and Arg protonated, and His
residues were neutral. The protein, modeled with the AMBER 99SB*-ILDN force
field47,48, was centered in a dodecahedral box with the edges at least 10 Å away
from the protein. The system was solvated with TIP3P water molecules49 and the
net charge was neutralized with sodium ions. Periodic boundary conditions were
imposed, where the long-range electrostatic interactions were calculated using the
particle mesh Ewald method50. The short-range nonbonded interactions were
calculated under the cutoff of 10 Å. All bonds were constrained using the LINCS
algorithm51, and a 2 fs integration time step was used. The minimized system
(2000 steps, steepest descent algorithm) was gradually heated and equilibrated for
0.2 ns in the NVT ensemble (at 298 K, velocity-rescaling thermostat)52, where the
protein atoms were restrained using a force constant of 1000 kJ mol−1 nm−2. In the
following 2.5 ns long NPT equilibration (at 1 bar, Berendsen barostat53), the
restraints were gradually reduced to 5 kJ mol−1 nm−2. The unrestrained produc-
tion HREX-MD was performed under constant temperature and pressure, using
the velocity-rescaling thermostat and the Parrinello–Rahman barostat54.
Six replicas were used in each HREX-MD simulation, where the hot region55
included Trp50 and residues in a 4 Å sphere around it (i.e., 9–11, 48–52, 80–81,
101, 128, 201, and 222). The Hamiltonian scaling factors for the nonbonded
interactions and proper dihedrals in the hot region were 1.000, 0.922, 0.850, 0.784,
0.723, and 0.667. The exchange between replicas was attempted every 4 ps during
200 ns simulations, giving the average exchange acceptance ratio of 35–40%. The χ-
angles used for the analysis were extracted every 2.5 ps from the unperturbed
replica (i.e., the one with the Hamiltonian scaling factor of 1.0). The backbone
RMSD profiles for all unperturbed replicas are shown in Supplementary Fig. 7. The
accumulated sampling time for one HREX-MD simulation was 1.2 μs, and 7.2 μs
over all systems.
Empirical valence bond simulations: Empirical valence bond simulations were
performed using Q56, version 5.10, and the OPLS-AA force field57. All non-
standard force field parameters used to describe the substrate and product
molecules were obtained using Macromodel 9.1, version 1158. The following crystal
structures were simulated: (4Z08), and (5D2W) for R1 (both with Trp50 in
conformation A), (5D30) with Trp50 in low occupancy (conformation A) and high
occupancy (conformation B) for R5,(6DC1) chain A and (5D33) chain A for R7
(Trp50 conformations A and B, respectively), and (5D38) chain A and (6CT3)
chain A for R7-2 (Trp50 conformations B and C, respectively). The 5-
nitrobenzisoxazole substrate was either overlaid with the product crystallized in the
active site, or in the absence of a product manually placed in the active site, in such
a way as to optimize the alignment of the donor-hydrogen-acceptor between the
substrate and the Glu101 side chain, as well as to maximize stabilizing interactions
from the surrounding residues. The entire system was then solvated in a 20 Å
radius of TIP3P water molecules49, subject to surface-constrained all-atom solvent
(SCAAS) boundary conditions56,59, and centered on the Cδ atom of Glu101. The
system was modeled using a multilayer approach, in which all atoms within the
inner 85% of this water droplet were allowed to move freely, the atoms in the
external 15% of the droplet were restrained to their crystallographic positions using
a 10 kcal mol−1 Å−2 harmonic restraint, and all atoms outside the droplet were
fixed at their crystallographic positions using a 200 kcal mol−1 Å−2 restraint. All
residues within the mobile region (i.e., the inner 85%) were protonated based on
examination of expected protonation states using PROPKA 3.122, and all residues
falling outside the mobile region were kept in their neutral forms to avoid
introducing system instabilities due to the presence of charged residues outside the
water droplet (note that this does not introduce structural instabilities as these
atoms are restrained to their crystallographic positions).
All simulations were performed using the Berendsen thermostat53 with the
leapfrog integrator, and with the solute and solvent coupled to individual heat
baths. A 10 Å cutoff was used for the calculation of nonbonded interactions (with
the exception of reacting atoms, which were subject to a 99 Å cutoff, i.e., essentially
no cutoff), and electrostatic interactions for all atoms falling beyond this cutoff
were approximated using the local reaction field approach60, with a nonbonded
pairlist update every 30 fs. The bonds to hydrogen atoms were constrained using
the SHAKE algorithm61. All systems were subjected to an initial 3 ps minimization
at 1 K and 0.1 fs step size to remove bad contacts in the system, during which time
a 200 kcal mol−1 Å−2 harmonic restraint was applied to all solute atoms to keep
them to their crystallographic positions. The step size was then increased to 1 fs for
the remainder of the simulation time, and the temperature was gradually increased
to 300 K while dropping the restraint to 0.5 kcal mol−1 Å−2 on only the reacting
atoms (not taking into account the restraint on atoms outside the mobile region),
over a total of 210 ps of simulation time. Once each system had been heated to
300 K, it was subjected to a further 30 ns of equilibration. Each equilibration was
performed three times with three different sets of initial velocities, leading to 90 ns
of equilibration time per system, and 720 ns of equilibration time over all systems.
The corresponding backbone root mean square deviations are shown in
Supplementary Fig. 15.
For each system, the endpoints of the three equilibration runs were then used as
starting structures for the subsequent EVB simulations27. Three additional
equilibration runs of 500 ps in length were performed from each of these starting
points, using random velocities, in order to generate nine discrete starting points
for our EVB simulations of each system. Our EVB calculations were performed
using a simple two-state model, using the valence bond states described in
Supplementary Figs. 8 and 16 (see also refs. 15,28). The EVB free energy
perturbation/umbrella sampling (EVB-FEP/US) calculations were performed in 51
individual mapping frames of 100 ps simulation length per frame, leading to a total
of 5.1 ns simulation time per individual EVB trajectory, 45.9 ns simulation time per
system, and 367 ns simulation time over all systems (in addition to the
equilibration time leading to a total simulation time of 1.09 μs).
The EVB parameters were calibrated using the uncatalyzed background reaction
in aqueous solution as a baseline, which was modeled using the 4-
nitrobenzisoxazole substrate and propionate as a model for Glu101 (again, see also
ref. 28). All simulations of this reference state were performed using the same
protocol as for the corresponding enzymatic reaction, with the exception that a
larger harmonic restraint of 1.0 kcal mol−1 Å−2 was placed on the reacting atoms
to stop them from drifting out of the simulation sphere. The EVB off-diagonal
element and gas-phase shift, which are described in detail in e.g. ref. 27, were
adjusted to reproduce an activation-free energy of 21.2 kcal mol−1 in aqueous
solution based on the calibration provided in refs. 15,28, and the same EVB
parameters were then used unchanged to model the reaction in all enzyme variants.
This then provides a common reference point to compare the relative energies of
all enzyme variants to each other. All EVB parameters used in this work are
provided in Supplementary Tables 10 to 21 (Supplementary Fig. 16). Finally,
all energy analyses were performed using the Q simulation package and Qtools
0.5.10 62, the RMSD and clustering analyses were performed using GROMACS45
(the clustering algorithm described by Daura et al.63, with the cutoff of 0.5 Å for the
protein atoms), and the geometry analysis was performed using the MDTraj
library64.
Computational tunneling evaluation in the Kemp elimination. All molecular
orbital theory and density functional theory calculations were carried out with
Gaussian 09 software package65. Geometries and frequencies of all species were
calculated using M06-2X functional. All species were optimized in vacuo or in a
field of solvent using SMD/M06-2×/6–31+G(d,p) method66 with water. All
transition state structures were characterized with a single imaginary frequency and
minimum with zero imaginary frequencies. The tunneling probability was eval-
uated using the reaction-path variational transition state theory with multi-
dimensional tunneling (RP-VTST/MT) method67. These calculations were
performed with Polyrate 2010-A via the Gaussrate 2009-A interface to Gaussian
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09 65. Gaussian archive entries of the optimized geometries are provided in Sup-
plementary Note 1.
Data availability
The crystal structures of KE07 variants, with and without ligand, have been deposited in
the Protein Data Bank under accession codes 6C7H, 4Z08, 5D2T, 5D2V, 5D2W, 6C7V,
6C7M, 6DNJ, 6C7T, 6C8B, 5D30, 5D32, 5D33, 6CAI, 6D31, 5D38, 6CT3. PDB validation
reports are all available at www.rcsb.org. All relevant data are available from the cor-
responding author upon request.
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